English  |  正體中文  |  简体中文  |  0  
???header.visitor??? :  51646578    ???header.onlineuser??? :  875
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"wu cheng chung"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 6-15 of 44  (5 Page(s) Totally)
1 2 3 4 5 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2018-09-10T09:14:11Z The binding affinity and molecular basis of the structure-binding relationship between urinary tamm-horsfall glycoprotein and tumor necrosis factor-α Chang, Juliana; Li, Ko-Jen; Lee, Po-Huang; Siao, Sue-Cien; Siao, Sue-Cien; Chen, Yu-Hsuan; Chen, Yu-Hsuan; Lin, Deng-Yn; Wu, Tsai-Hung; Wu, Cheng-Chung; Wu, Tsai-Hung; Jeng, Long-Bin; Tsai, Chang-Youh; Tsai, Chang-Youh; Lin, Yih-Jyh; Yu, Chia-Li; Yu, Chia-Li; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Yang, Mei-Due; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer; 胡瑞恒; 劉俊人; 陳培哲; 李伯皇; 何明志; Wu, C.-H. and Li, K.-J. and Siao, S.-C. and Chen, Y.-H. and Wu, T.-H. and Tsai, C.-Y. and Yu, C.-L.; Wu, Cheng-Han;Li, Ko-Jen;Siao, Sue-Cien;Chen, Yu-Hsuan;Wu, Tsai-Hung;Tsai, Chang-Youh;Yu, Chia-Li; Wu, Cheng-Han;Li, Ko-Jen;Siao, Sue-Cien;Chen, Yu-Hsuan;Wu, Tsai-Hung;Tsai, Chang-Youh;Yu, Chia-Li; 余家利;吳政翰; Liu, Chun-Jen; Wu, Cheng-Han; CHENG-HAN WU; Wu, Cheng-Han; Li, Ko-Jen
臺大學術典藏 2018-09-10T07:26:51Z Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage Liu, C.-J. and Lee, P.-H. and Lin, D.-Y. and Wu, C.-C. and Jeng, L.-B. and Lin, P.-W. and Mok, K.-T. and Lee, W.-C. and Yeh, H.-Z. and Ho, M.-C. and Yang, S.-S. and Lee, C.-C. and Yu, M.-C. and Hu, R.-H. and Peng, C.-Y. and Lai, K.-L. and Chang, S.S.-C. and Chen, P.-J.; 劉俊人;李伯皇;胡瑞恆;吳誠中;鄭隆賓;林炳文;莫景棠;葉宏仁;何明志;楊勝舜;陳培哲; LIU, CHUN-JEN;LEE, PO-HUANG;HU, REY-HENG;WU, CHENG-CHUNG;JENG, LONG-BIN;LIN, PIN-WEN;MOK, KING-TONG;YEH, HONG-ZEN;HO, MING-CHIH;YANG, SHENG-SHUN;CHEN, PEI-JER; MING-CHIH HO; PO-HUANG LEE; CHUN-JEN LIU; PEI-JER CHEN; REY-HENG HU; LIU, CHUN-JEN; LEE, PO-HUANG; HU, REY-HENG; WU, CHENG-CHUNG; JENG, LONG-BIN; LIN, PIN-WEN; MOK, KING-TONG; YEH, HONG-ZEN; HO, MING-CHIH; YANG, SHENG-SHUN; CHEN, PEI-JER
國立臺灣大學 2016 The Hepatitis Viral Status in Patients With Hepatocellular Carcinoma: a Study of 3843 Patients From Taiwan Liver Cancer Network Chang, Il-Chi; Huang, Shiu-Feng; Chen, Pei-Jer; Chen, Chi-Ling; Chen, Chao-Long; Wu, Cheng-Chung; Tsai, Cheng-Chung; Lee, Po-Huang; Chen, Miin-Fu; Lee, Chuan-Mo; Yu, Hsien-Chung; Lo, Gin-Ho; Yeh, Chau-Ting; Hong, Chih-Chen; Eng, Hock-Liew; Wang, John; Tseng, Hui-Hwa; Hsiao, Cheng-Hsiang; Wu, Hong-Dar Isaac; Yen, Tseng-Chang; Liaw, Yun-Fan; 蕭正祥; 陳培哲; 李伯皇; 陳祈玲
大葉大學 2015-11 Methylation-silencing RCC1 expression is associated with tumorigenesis and depth of invasion in gastric cancer. Lin, Yi-Ling;Ling, Chen Hsiao;Cheng, Shao-Bin;Yeh, Dah-Cherng;Huang, Chu-Chun;P’eng, Fang-Ku;Tsai, Tung-Chou;Wu, Cheng-Chung;Chen, Chuan-Mu
國立臺灣大學 2015 Akt suppresses DLK for maintaining self-renewal of mouse embryonic stem cells Wu, Cheng-Chung; Wu, Hong-Jin; Wang, Chia-Hui; Lin, Chia-Hua; Hsu, Shu-Ching; Chen, Yi-Rong; Hsiao, Michael; Schuyler, Scott C.; Lu, Frank Leigh; Ma, Nianhan; Lu, Jean; 呂立
國立臺灣大學 2015 Randomized, phase III trial of adjuvant adeforvir vs. therapeutic lamivudine in post-operative BCLC stage 0 or A HBV-related HCC: The Taiwan Cooperative Oncology Group T1206 study Chen, Li-Tzong; Jeng, Long-Bin; Hsiao, Chin-Fu; Wu, Cheng-Chung; Lee, Wei-Chen; Wang, Tsang-En; Lee, Po-Huang; Chen, Chao-Long; Chen, I-Su; Lee, King-Teh; Hsieh, Chung-Bao; Hwang, Wei-Shou; Yang, Mei-Due; Yang, Yang-Sen; Lin, Deng-Yn; Chen, Miin-Fu; Chen, Pei-Jer; 陳培哲; 李伯皇
國立成功大學 2014-08-28 Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence Liu, Chun-Jen; Chang, Juliana; Lee, Po-Huang; Lin, Deng-Yn; Wu, Cheng-Chung; Jeng, Long-Bin; Lin, Yih-Jyh; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Yang, Mei-Due; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer
國立成功大學 2014-04 A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer Chao, Yee; Hsieh, Jan-Sing; Yeh, Hsien-Tang; Su, Yu-Chieh; Wu, Cheng-Chung; Chen, Jen-Shi; Tai, Cheng-Jeng; Bai, Li-Yuan; Yeh, Kun-Huei; Su, Wu-Chou; Li, Chung-Pin
臺北醫學大學 2014 A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer Chao, Yee;Hsieh, Jan-Sing;Yeh, Hsien-Tang;Su, Yu-Chieh;Wu, Cheng-Chung;Chen, Jen-Shi;Tai, Cheng-Jeng;Bai, Li-Yuan;Yeh, Kun-Huei;Su, Wu-Chou;Li, Chung-Pin
臺北醫學大學 2014 Is Liver Resection for Hepatocellular Carcinoma in Cirrhotic Patients with High Preoperative Serum Alanine Aminotransferase Level Unadvisable? Lai, Chia-Yu;Wu, Cheng-Chung;Wang, John;Yu, Cheng-Chan;Cheng, Shao-Bin;Yeh, Dar-Cherng;Peng, Fang-Ku

Showing items 6-15 of 44  (5 Page(s) Totally)
1 2 3 4 5 > >>
View [10|25|50] records per page